Formycon AG ( 0W4N.L) - Key Metrics
0W4N.L Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | ? | ? | ? | ? |
| 2025Q2 | ? | ? | ? | ? |
| 2024Q4 | €2.42 | -€6.54 | €0.43 | €0.40 |
| 2024Q2 | €1.56 | -€0.58 | -€1.80 | -€1.86 |
| 2023Q4 | €2.11 | €4.61 | -€0.08 | -€0.62 |
0W4N.L Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | ? | ? |
| 2025Q2 | ? | ? |
| 2024Q4 | ? | -2.03 |
| 2024Q2 | ? | -23.03 |
| 2023Q4 | ? | 3.06 |
0W4N.L Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q4 | 0.88% | ? |
| 2025Q2 | 1.34% | ? |
| 2024Q4 | 0.76% | ? |
| 2024Q2 | -3.46% | ? |
| 2023Q4 | -1.10% | ? |
0W4N.L
Price: €19.76
52 week price:
Earnings Per Share: -1.22 EUR
Exchange: LSE
Sector: Healthcare
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Country: Germany
Market Capitalization: 150.0 million